| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735295 | Hepatobiliary & Pancreatic Diseases International | 2017 | 10 Pages |
Abstract
In this interferon-free era, PegIFN-based regimens remain a safe and effective option for selected HCV patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Yan Huang, Ming-Hui Li, Min Hou, Yao Xie,